Newborn screening for congenital adrenal hyperplasia in the Netherlands

Pediatrics

Volumn 108, Issue 6, 2001, Pages 1320-1324

  Van Der Kamp, Hetty J ^a   Noordam, Kees ^b   Elvers, Bert ^c   Van Baarle, Maja ^d   Otten, Barto J ^b   Verkerk, Paul H ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d IJSSELLAND HOSPITAL   (Netherlands)

^e TNO   (Netherlands)

Author keywords

Congenital adrenal hyperplasia; Costs; Cutoff levels; Neonatal screening; Sensitivity; Specificity

Indexed keywords

SODIUM;

ARTICLE; BIRTH WEIGHT; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEWBORN SCREENING; PATIENT MONITORING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SALT LOSING NEPHRITIS;

ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NETHERLANDS; PILOT PROJECTS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0035199542     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.108.6.1320     Document Type: Article

References (14)

1. Current status of neonatal screening for congenital adrenal hyperplasia
2. The British Paediatric Surveillance Unit-a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995
3. Neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia-the role of CYP21 analysis
4. Jaarverslag Nederlands signalerings-centrum kindergeneeskunde
5. Der genitalbefund beim pseudohermaphroditismus femininus des kongenitalen adrenogenitalen syndroms
6. Neonatal screening of congenital adrenal hyperplasia due to 21- hydroxylase deficiency: Lille experience 1980-1996
7. Congenital adrenal hyperplasia: Neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995
8. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age
9. Screening of half a million Swedish newborn infants for congenital adrenal hyperplasia
10. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden
11. Effect of newborn screening for congenital adrenal hyperplasia
12. Learning disabilities in children with congenital adrenal hyperplasia
13. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency